• 154,640+ Medical Conferences
  • 285 Specialties
  • 11,298 Organizers
  • 156,490 Speakers
  • 159 Countries
  • 4,788 Cities
CME Conference Registrations Sold


Psychosocial Benefit Seen With Probiotic, Peanut Oral Immunotx

Psychosocial Benefit Seen With Probiotic, Peanut Oral Immunotx

Fri, Nov 17, 2017

FRIDAY, Nov. 17, 2017 (HealthDay News) -- Probiotic and peanut oral immunotherapy (PPOIT) has a sustained beneficial effect on psychosocial impact of food allergy after end-of-treatment, according to a study published online Oct. 20 in Allergy.

Audrey Dunn Galvin, Ph.D., from University College Cork in Ireland, and colleagues evaluated the impact of PPOIT on health-related quality-of-life (HRQL) among 51 participants in a randomized controlled trial. Participants completed questionnaires at pre-treatment, end-of-treatment, and three-months after end-of-treatment. Forty-two participants completed 12-month surveys.

The researchers found that PPOIT was associated with significant improvement in Food Allergy Quality of Life Questionnaire (FAQLQ; P = 0.02), with the mean difference at three months post-treatment (P = 0.05) and 12 months post-treatment (P = 0.005) exceeding the clinically important difference. Similarly, there were significant mean differences in Food Allergy Independent Measure (FAIM) at three months (P = 0.03) and 12 months (P = 0.04). Among the placebo group, post-treatment FAQLQ and FAIM remained unchanged from pre- to post-treatment.

"Treatment was not associated with reduced HRQL relative to baseline in either PPOIT or placebo groups, indicating that PPOIT was well tolerated and psychological well-being was not negatively impacted," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)